Table 2:
Descriptive Changes in LVEF From Baseline to Follow-up
| Variable of Interest | Overall (N=659) | LBBB (N=111) | WQRS (N=59) | NQRS (N=489) |
|---|---|---|---|---|
| Baseline LVEF, mean ± SD | 25.6 ± 7.02 | 24.7 ± 6.34 | 26.4 ± 6.90 | 25.8 ± 7.17 |
|
| ||||
| Follow-up LVEF, mean ± SD | 33.7 ± 12.42 | 28.1 ± 11.46 | 31.3 ± 11.26 | 35.3 ± 12.36 |
|
| ||||
| Change in LVEF, mean ± SD | 8.06 ± 11.76 | 3.41 ± 9.43 | 4.86 ± 9.22 | 9.50 ± 12.17 |
|
| ||||
| Follow-up LVEF>35% | 250 (38%) | 25 (23%) | 16 (27%) | 209 (43%) |
|
| ||||
| LVEF Change Categories, % | ||||
| Any LVEF worsening | 111 (17%) | 27 (24%) | 13 (22%) | 71 (15%) |
| Unchanged | 154 (23%) | 39 (35%) | 14 (24%) | 101 (21%) |
| + 1–14% | 193 (29%) | 29 (26%) | 22 (37%) | 142 (29%) |
| + > 15% | 201 (31%) | 16 (14%) | 10 (17%) | 175 (36%) |
|
| ||||
| Interval (in days) to Follow-up ECHO, median (IQR) | 131 (112–154) | 134 (116–156) | 127 (106–159) | 131 (111–153) |
|
| ||||
| Changes in LVEF from Baseline to Follow-up for Patients on GDMT. | ||||
|
| ||||
| N=445 | N=76 | N=39 | N=330 | |
|
| ||||
| Baseline LVEF, mean ± SD | 25.2 ± 7.10 | 24.2 ± 6.50 | 25.8 ± 7.14 | 25.4 ± 7.22 |
|
| ||||
| Follow-up LVEF, mean ± SD | 33.9 ± 12.54 | 27.8 ± 11.38 | 30.9 ± 11.02 | 35.6 ± 12.47 |
|
| ||||
| Change in LVEF, mean ± SD | 8.61 ± 11.74 | 3.59 ± 9.32 | 5.05 ± 9.24 | 10.19 ± 12.11 |
|
| ||||
| Interval (in days) to Follow-up ECHO, median (IQR) | 132 (111–155) | 133 (116–152) | 132 (111–155) | 127 (106–155) |